Abstract
A 55-year-old woman has been on carbamazepine for 30 years with excellent control of her partial-onset seizures. In the past when an attempt was made to switch her to lamotrigine or levetiracetam, she experienced seizure recurrence as soon as carbamazepine was tapered off. You order vitamin D levels which are borderline low and a DXA scan which shows osteoporosis of hip and thoracic spine. What is your advice to her for future management of her epilepsy in this context?
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Carbone LD, Johnson KC, Robbins J, et al. Antiepileptic drug use, falls, fractures, and BMD in postmenopausal women: findings from the women’s health initiative (WHI). J Bone Miner Res. 2010;25:873–81.
Souverein PC, Webb DJ, Weil JG, et al. Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy. Neurology. 2006;66:1318–24.
Persson HB, Alberts KA, Farahmand BY, Tomson T. Risk of extremity fractures in adult outpatients with epilepsy. Epilepsia. 2002;43:768–72.
Lazzari AA, Dussault PM, Thakore-James M, Gagnon D, Baker E, Davis SA, Houranieh AM. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy—antiepileptic drug and osteoporosis prevention trial. Epilepsia. 2013;54:1997–2004.
Wang S, Mintzer S, Skidmore C, et al. Seizure recurrence and remission after switching antiepileptic drugs. Epilepsia. 2013;54(1):187–93.
Bazil C. Comprehensive care of the epilepsy patient—control, comorbidity and cost. Epilepsia. 2004;45 Suppl 6:3–12.
Institute of Medicine. Epilepsy across the spectrum: promoting health and understanding. Washington: The National Academic Press; 2012.
Klenerman P, Sander J, Shorvon S. Mortality in patients with epilepsy: a study of patients in long term residential care. J Neurol Neurosurg Psychiatry. 1993;56(2):149–52.
U.S. Department of Health and Human Services. Bone health and osteoporosis: a report of the Surgeon General. Rockville: US Department of Health and Human Services, Office of the Surgeon General; 2004.
Sheth R, Harden C. Screening for bone health in epilepsy. Epilepsia. 2007;48 Suppl 9:39–41.
Pack A. The association between antiepileptic drugs and bone disease. Epilepsy Curr. 2003;3(3):91–5.
Mikati MA, Dib L, Yamout B, et al. Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone. Neurology. 2006;67:2005–14.
Gross R, Gidal B, Pack A. Antiseizure drugs and reduced bone density. Neurology. 2004;62:E24–5.
Fekete S, Simko J, Gradosova I, et al. The effect of levetiracetam on rat bone mass, structure and metabolism. Epilepsy Res. 2013;107(1–2):56–60.
Simko J, Fekete S, Gradosova I, et al. The effect of topiramate and lamotrigine on rate bone mass, structure and metabolism. J Neurol Sci. 2014;340(1–2):80–5.
Pack AM. Treatment of epilepsy to optimize bone health. Curr Treat Options Neurol. 2011;13:346–54.
Verrotti A, Coppola G, Parisi P, Mohn A, Chirelli F. Bone and calcium metabolism and antiepileptic drugs. Clin Neurol Neurosurg. 2010;112:1–10.
Pack AM, Morrell MJ, Randall A, McMahon DJ, Shane E. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. Neurology. 2008;70:1586–93.
Vestergaard P, Rejnmark L, Mosekilde L. Anxiolytics and sedatives and risk of fractures: effects of half-life. Calcif Tissue Int. 2008;82:34–43.
Ensrud KE, Walczak TS, Blackwell TL, Ensrud ER, Barrett-Connor E, Orwoll ES. Antiepileptic drug use and rates of hip bone loss in older men: a prospective study. Neurology. 2008;71:723–30.
El-Hajj Fuleihan G, Dib L, Yamout B, Sawaya R, Mikati MA. Predictors of bone density in ambulatory patients on antiepileptic drugs. Bone. 2008;43:149–55.
Vestergaard P. Effects of antiepileptic drugs on bone health and growth potential in children with epilepsy. Paediatr Drugs. 2015;17:141–50.
Guo CY, Ronen GM, Atkinson SA. Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy. Epilepsia. 2001;42:1141–7.
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–30.
Hansen KE, Johnson RE, Chambers KR, Johnson MG, Lemon CC, Vo TN, et al. Treatment of vitamin D insufficiency in postmenopausal women: a randomized clinical trial. JAMA Intern Med. 2015;175(10):1612–21.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Crawford, P., Serrano, E.A., Sazgar, M. (2016). Bone Health in Women with Epilepsy. In: Sazgar, M., Harden, C. (eds) Controversies in Caring for Women with Epilepsy. Springer, Cham. https://doi.org/10.1007/978-3-319-29170-3_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-29170-3_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-29168-0
Online ISBN: 978-3-319-29170-3
eBook Packages: MedicineMedicine (R0)